{"title":"有机体的前景与挑战：从 \"人源化 \"到 \"人源化\"。","authors":"Wenyan Wang, Yang-Xin Fu","doi":"10.1016/j.stem.2024.02.002","DOIUrl":null,"url":null,"abstract":"<p><p>Kastenschmidt et al.<sup>1</sup> present a groundbreaking organoid culture model for follicular lymphoma, which is capable of maintaining stable compositions of B and T cells. This model is utilized in testing bispecific antibodies in effective killing of tumor B cells with the activation of T cells.</p>","PeriodicalId":93928,"journal":{"name":"Cell stem cell","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-03-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Promises and challenges of organoids: From humanized to human derived.\",\"authors\":\"Wenyan Wang, Yang-Xin Fu\",\"doi\":\"10.1016/j.stem.2024.02.002\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Kastenschmidt et al.<sup>1</sup> present a groundbreaking organoid culture model for follicular lymphoma, which is capable of maintaining stable compositions of B and T cells. This model is utilized in testing bispecific antibodies in effective killing of tumor B cells with the activation of T cells.</p>\",\"PeriodicalId\":93928,\"journal\":{\"name\":\"Cell stem cell\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-03-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cell stem cell\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/j.stem.2024.02.002\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cell stem cell","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.stem.2024.02.002","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
卡斯滕施密特（Kastenschmidt）等人1 提出了一种突破性的滤泡淋巴瘤类器官培养模型，该模型能够保持 B 细胞和 T 细胞的稳定组成。该模型可用于测试双特异性抗体在激活 T 细胞的同时有效杀伤肿瘤 B 细胞的能力。
Promises and challenges of organoids: From humanized to human derived.
Kastenschmidt et al.1 present a groundbreaking organoid culture model for follicular lymphoma, which is capable of maintaining stable compositions of B and T cells. This model is utilized in testing bispecific antibodies in effective killing of tumor B cells with the activation of T cells.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
